Arctic Bioscience – Mandatory notification of trade
Daniele Mancinelli, CTO in Arctic Bioscience, has today bought 6.840 shares in Arctic Bioscience at an average price of NOK 12,05 per share. Following the transaction, Daniele Mancinelli holds 6.840 shares and 101.570 share options in Arctic Bioscience personally, and 76.180 shares indirect through 60% ownership in Futuron AS.
Please refer to the attached notification of trading for further details.
This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 number 3 and the Norwegian Securities Trading Act § 5-12.